Vera Therapeutics VERA
NASDAQ VERA
$30.42 -0.57 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vera Therapeutics (VERA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Vera Therapeutics' Return on Capital Employed [ROCE] came in at -78.59% for Q2 2026, down 36.50 percentage points from -42.09% a year earlier and down 18.03 percentage points from the prior quarter.

Analysis

Vera Therapeutics (VERA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Vera Therapeutics' Return on Capital Employed [ROCE] was -49.16%, down 6.32 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a four-year change of +6.82 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -42.84% in FY2024 (+34.92 pp), -77.76% in FY2023 (+33.11 pp), -110.87% in FY2022 (-54.90 pp) and -55.97% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q4 2022.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of -5.93 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2022 (a gain of 65.47 percentage points), and the weakest in Q4 2022 (a drop of 42.79 percentage points).
  • Business Quant data shows VERA's Return on Capital Employed [ROCE] at -60.56% (Q1 2026), -55.09% (Q4 2025) and -53.38% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Vera Therapeutics 2.19 Bn 2.19 Bn - -78.59%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -78.59%
Mar 31, 2026 -60.56%
Dec 31, 2025 -55.09%
Sep 30, 2025 -53.38%
Jun 30, 2025 -42.09%
Mar 31, 2025 -31.63%
Dec 31, 2024 -34.34%
Sep 30, 2024 -40.76%
Jun 30, 2024 -30.07%
Mar 31, 2024 -36.01%
Dec 31, 2023 -66.55%
Sep 30, 2023 -67.53%
Jun 30, 2023 -63.83%
Mar 31, 2023 -71.53%
Dec 31, 2022 -85.92%
Sep 30, 2022 -59.53%
Jun 30, 2022 -40.05%
Mar 31, 2022 -44.74%
Dec 31, 2021 -43.13%
Sep 30, 2021 -66.81%
API Access

Vera Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VERA&period=max&api_key=YOUR_API_KEY